Regeneron Pharmaceuticals Ownership | Who Owns Regeneron Pharmaceuticals?


OverviewForecastRevenueFinancialsChartTranscripts

Regeneron Pharmaceuticals Ownership Summary


Regeneron Pharmaceuticals is owned by 87.05% institutional investors, 1.56% insiders, and 11.39% retail investors. Fmr is the largest institutional shareholder, holding 9.88% of REGN shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 3.13% of its assets in Regeneron Pharmaceuticals shares.

REGN Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockRegeneron Pharmaceuticals87.05%1.56%11.39%
SectorHealthcare Stocks 47.31%8.01%44.69%
IndustryBiotech Stocks 45.43%7.81%46.75%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Fmr10.65M9.88%$11.19B
Vanguard group8.99M8.34%$9.45B
Blackrock8.45M7.84%$8.88B
Jpmorgan chase8.28M7.68%$8.70B
State street4.84M4.49%$5.09B
Capital world investors4.64M4.30%$4.88B
Capital investors3.13M2.91%$3.29B
Geode capital management2.42M2.24%$2.53B
Dodge & cox2.32M2.15%$2.43B
Franklin resources1.92M1.78%$2.02B

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Orion investment29.49K12.35%$30.99M
Bronte capital management pty139.45K11.47%$146.57M
Mcdonald capital investors inc/ca139.20K9.14%$146.30M
Rk asset management9.11K8.27%$9.57M
R.p. boggs8.87K5.64%$9.32M
Dcf advisers10.40K5.63%$10.93M
Ellerson group inc /adv6.99K5.59%$7.34M
Healthinvest partners ab6.89K4.42%$7.24M
Krensavage asset management7.85K3.79%$8.25M
Aimz investment advisors9.98K3.76%$10.49M

Top Buyers

HolderShares% AssetsChange
Norges bank1.13M0.18%1.13M
Jpmorgan chase8.28M0.71%550.14K
Franklin resources1.92M0.62%228.80K
Capital research global investors558.79K0.13%164.60K
Ubs asset management americas847.68K0.26%163.12K

Top Sellers

HolderShares% AssetsChange
Global assets advisory---352.83K
Fmr10.65M0.72%-144.60K
Marshall wace, llp58.87K0.08%-141.51K
Blackrock8.45M0.20%-122.29K
Pictet asset management sa293.76K0.35%-110.48K

New Positions

HolderShares% AssetsChangeValue
Norges bank1.13M0.18%1.13M$1.18B
Mirae asset global etfs84.38K0.21%84.38K$88.68M
Corebridge financial37.46K0.22%37.46K$39.38M
Orion investment29.49K12.35%29.49K$30.99M
Fjarde ap-fonden (the fourth swedish national pensionfund)29.25K0.35%29.25K$30.75M

Sold Out

HolderChange
Institutional & family asset management-1.00
Tfo-tdc-1.00
Financial gravity asset management-1.00
Triad wealth partners-1.00
Impact partnership wealth-1.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20241,358-0.29%93,841,3672.15%871.20%6504.67%422-5.59%
Mar 31, 20241,3623.34%91,870,5690.66%851.16%6211.31%4470.68%
Dec 31, 20231,3187.15%91,271,9630.24%851.17%61321.15%4440.23%
Sep 30, 20231,2301.49%91,054,257-1.44%851.15%5064.76%443-4.94%
Jun 30, 20231,212-2.10%92,386,029-6.62%861.01%483-15.11%4669.65%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv3.44M3.13%178.74K
Capital Group Growth Fnd of Amer Comp3.14M2.84%-92.79K
American Funds Growth Fund of Amer A3.14M2.84%-92.79K
Vanguard Institutional 500 Index Trust2.78M2.53%5.21K
Fidelity Contrafund2.67M2.43%9.44K
Invesco QQQ Trust2.10M1.91%-9.74K
JPMorgan Large Cap Growth I1.64M1.49%-
Dodge & Cox Stock I1.56M1.41%-
Fidelity 500 Index1.30M1.19%-2.23K
American Funds New Perspective A1.30M1.18%-

Recent Insider Transactions


DateNameRoleActivityValue
Nov 01, 2024McCourt Marion EVP CommercialSell$844.61K
Oct 01, 2024RYAN ARTHUR F-Sell$5.22K
Oct 01, 2024RYAN ARTHUR F-Sell$9.40K
Oct 01, 2024RYAN ARTHUR F-Sell$7.32K
Oct 01, 2024RYAN ARTHUR F-Sell$1.04K

Insider Transactions Trends


DateBuySell
2024 Q4-18
2024 Q3-117
2024 Q2-113
2024 Q1-116
2023 Q4-60

REGN Ownership FAQ


Who Owns Regeneron Pharmaceuticals?

Regeneron Pharmaceuticals shareholders are primarily institutional investors at 87.05%, followed by 1.56% insiders and 11.39% retail investors. The average institutional ownership in Regeneron Pharmaceuticals's industry, Biotech Stocks , is 45.43%, which Regeneron Pharmaceuticals exceeds.

Who owns the most shares of Regeneron Pharmaceuticals?

Regeneron Pharmaceuticals’s largest shareholders are Fmr (10.65M shares, 9.88%), Vanguard group (8.99M shares, 8.34%), and Blackrock (8.45M shares, 7.84%). Together, they hold 26.06% of Regeneron Pharmaceuticals’s total shares outstanding.

Does Blackrock own Regeneron Pharmaceuticals?

Yes, BlackRock owns 7.84% of Regeneron Pharmaceuticals, totaling 8.45M shares as of Jun 2024. This represents 0.20% of BlackRock's total assets, with a market value of 8.88B$. In the last quarter, BlackRock decreased its holdings by -122K shares, a -1.43% change.

Who is Regeneron Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Orion investment is Regeneron Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 12.35% of its assets in 29.49K Regeneron Pharmaceuticals shares, valued at 30.99M$.

Who is the top mutual fund holder of Regeneron Pharmaceuticals shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Regeneron Pharmaceuticals shares, with 3.13% of its total shares outstanding invested in 3.44M Regeneron Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools